Oct 03, 2011, 05.43 PM | Source: CNBC-TV18
Pharma major Wockhardt now has additional time on its hands to finalise a formal repayment plan for its overseas bond holders.
The company has total dues of Rs 358 crore it was supposed to revert to the Bombay High Court with a detailed plan by October 3.
It now has extra time as the court today adjourned the case to October 11.
A group of bondholders led by the bond trustee of the Bank of New York Mellon, Sun Pharma Global and hedge fund QVT besides some creditors had taken Wockhardt to court, filing a wind-up petition, after the company defaulted on repayment of its USD 110-million FCCBs, in 2009.
Wockhardt stock price
On May 27, 2016, Wockhardt closed at Rs 926.75, up Rs 27.75, or 3.09 percent. The 52-week high of the share was Rs 1748.20 and the 52-week low was Rs 706.35.
The company's trailing 12-month (TTM) EPS was at Rs 2.97 per share as per the quarter ended March 2016. The stock's price-to-earnings (P/E) ratio was 312.04. The latest book value of the company is Rs 99.95 per share. At current value, the price-to-book value of the company is 9.27.
Shahina Mukadam, Independent Market Expert is of t
Sandeep Wagle of powermywealth.com advises selling
The company had posted a net profit of Rs 34.08 cr
Wockhardt in its meeting held on May 06, 2016, has
In an interview with CNBC-TV18, market analyst SP
HeidelbergCement India has reported a sales turnov
Medi-Caps has reported a sales turnover of Rs 6.77